Viridian Therapeutics Inc. (0K1R)
Market Closed
3 Jun, 15:30
LSE 
$
16. 32
+0.42
+2.64%
$
- Market Cap
- P/E Ratio
- Div Yield
4,246 Volume
-4.96 Eps
$ 15.9
Previous Close Want to track 0K1R and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
0K1R Earnings Reports FAQ
What is the earnings per share (EPS) for 0K1R?
The current EPS is -4.96.
What is the company's earnings growth rate?
Viridian Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Viridian Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Viridian Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 0K1R at this time, as Viridian Therapeutics Inc has no recent EPS data to calculate it.
